Dabigatran in Patients With Nonvalvular Atrial Fibrillation

被引：3
|
作者：
Gage, Lawrence [1 ]
机构：
[1] Rochester Gen Hosp, Rochester Cardiopulm Grp, PC, Rochester, NY 14621 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2011年 / 58卷 / 05期
关键词：
D O I：
10.1016/j.jacc.2011.04.016
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：551 / 551
页数：1
相关论文
共 50 条
  • [31] Modern Approaches to Prevention of Thromboembolic Complications in Patients With Nonvalvular Atrial Fibrillation With a Direct Thrombin Inhibitor Dabigatran
    Savina, N. M.
    KARDIOLOGIYA, 2016, 56 (07) : 91 - +
  • [32] Dabigatran with or without concomitant Aspirin compared with Warfarin alone in patients with nonvalvular atrial fibrillation (PETRO study)
    Ezekowitz, Michael D.
    Reilly, Paul A.
    Nehmiz, Gerhard
    Simmers, Timothy A.
    Nagarakanti, Rangadham
    Parcham-Azad, Kambiz
    Pedersen, K. Erik
    Lionetti, Dominick A.
    Stangier, Joachim
    Wallentin, Lars
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (09): : 1419 - 1426
  • [33] ABO Blood Type and Response of Activated Partial Thromboplastin Time to Dabigatran in Nonvalvular Atrial Fibrillation Patients
    Suzuki, Shinya
    Otsuka, Takayuki
    Sagara, Koichi
    Semba, Hiroaki
    Kano, Hiroto
    Matsuno, Shunsuke
    Takai, Hideaki
    Kato, Yuko
    Uejima, Tokuhisa
    Oikawa, Yuji
    Nagashima, Kazuyuki
    Kirigaya, Hajime
    Kunihara, Takashi
    Yajima, Junji
    Sawada, Hitoshi
    Aizawa, Tadanori
    Yamashita, Takeshi
    CIRCULATION JOURNAL, 2015, 79 (10) : 2274 - 2277
  • [34] Association Between Dabigatran vs Warfarin and Risk of Osteoporotic Fractures Among Patients With Nonvalvular Atrial Fibrillation
    Lau, Wallis C. Y.
    Chan, Esther W.
    Cheung, Ching-Lung
    Sing, Chor Wing
    Man, Kenneth K. C.
    Lip, Gregory Y. H.
    Siu, Chung-Wah
    Lam, Joanne K. Y.
    Lee, Alan C. H.
    Wong, Ian C. K.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (11): : 1151 - 1158
  • [35] Cardiovascular, Bleeding, and Mortality Risks in Elderly Medicare Patients Treated With Dabigatran or Warfarin for Nonvalvular Atrial Fibrillation
    Graham, David J.
    Reichman, Marsha E.
    Wernecke, Michael
    Zhang, Rongmei
    Southworth, Mary Ross
    Levenson, Mark
    Sheu, Ting-Chang
    Mott, Katrina
    Goulding, Margie R.
    Houstoun, Monika
    MaCurdy, Thomas E.
    Worrall, Chris
    Kelman, Jeffrey A.
    CIRCULATION, 2015, 131 (02) : 157 - 164
  • [36] Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
    Yao, Xiaoxi
    Abraham, Neena S.
    Sangaralingham, Lindsey R.
    Bellolio, M. Fernanda
    McBane, Robert D.
    Shah, Nilay D.
    Noseworthy, Peter A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (06):
  • [37] A comparative study of the clinical benefits of rivaroxaban and dabigatran in patients with nonvalvular atrial fibrillation with high bleeding risk
    Liu, Penghui
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
  • [38] EFFICACY AND SAFETY OF THE DABIGATRAN MONOTHERAPY IN ELDERLY PATIENTS WITH STABLE CORONARY HEART DISEASE AND NONVALVULAR ATRIAL FIBRILLATION
    Xie, Dili
    Cheng, Biao
    Sheng, Yong
    Jin, Jing
    CLINICAL CARDIOLOGY, 2017, 40 : 9 - 10
  • [39] Management of Major Bleeding Events in Patients Treated With Dabigatran for Nonvalvular Atrial Fibrillation: A Retrospective, Multicenter Review
    Milling, Truman J.
    Fromm, Christian
    Ganetsky, Michael
    Pallin, Daniel J.
    Cong, Julie
    Singer, Adam J.
    ANNALS OF EMERGENCY MEDICINE, 2017, 69 (05) : 531 - 540
  • [40] A retrospective cohort study of the effectiveness and safety of dabigatran versus rivaroxaban in overweight patients with nonvalvular atrial fibrillation
    Yu, Meixiang
    Wang, Zi
    Zong, Liuliu
    Xu, Qing
    Li, Xiaoye
    Lv, Qianzhou
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (05) : 1149 - 1157
12345